Region — US. Neutral scientific reference — not offered for sale here.
Set region
Vallydia
ExploreShopToolsJournalTrustSearch ⌕
Explore  /  Syn-Ake (Dipeptide Diaminobutyroyl Benzylamide Diacetate)
Research reference — not for sale

Syn-Ake (Dipeptide Diaminobutyroyl Benzylamide Diacetate)

B
lead outcome
Appearance of expression/dynamic wrinkles…
grades vary by outcome ↓
Peptide
also called — Syn-Ake® / SYN®-AKE (trade name, dsm-firmenich, originally Pentapharm) · INCI: Dipeptide Diaminobutyroyl Benzylamide Diacetate (supplied in Glycerin/Aqua) · "snake-venom peptide" · sometimes described as a waglerin-1-mimetic tripeptide. Inspiration molecule: Waglerin-1
cosmeticanti-wrinkle (expression/dynamic lines)muscle-relaxing (topical, biomimetic)smoothing

"Botox from snake venom" — a genuinely beautiful biomimetic story, and a legitimate cosmetic ingredient. Syn-Ake is a rarity in this register: a real, approved cosmetic peptide with a great origin tale and honest topical data — not a gray-market injectable. Three threads: (1) it's inspired by the ve

In brief

Syn-Ake is a synthetic cosmetic dipeptide with one of skincare's best origin stories: it mimics Waglerin-1, a muscle-paralyzing toxin from the venom of the Temple Viper, reimagined by Swiss chemists (Pentapharm, 2001; now dsm-firmenich) as a needle-free, topical "Botox alternative." Its mechanism is genuinely elegant — it acts as a reversible antagonist of the muscle nicotinic acetylcholine receptor (mnAChR), binding the receptor's ε-subunit to dampen the nerve signal that makes facial muscles contract, so expression lines relax and soften. It's a legitimate, approved cosmetic ingredient (topical, not injected) with real in-vitro and in-vivo data: it reduces muscle-cell contraction substantially in vitro, and clinical cosmetic testing shows visibly reduced wrinkle depth over ~28 days, with good skin tolerance and a reversible effect. The honest framing: it's milder than Botox and works on the look of dynamic (expression) wrinkles, not deep structural ones — and, like all topical "muscle-relaxing" peptides, how much reaches muscle is inherently limited. For this register it's notable as a beautiful biomimetic story AND a genuine legal-lane cosmetic — the kind of ingredient that's actually sellable, honestly, with appearance claims.

Legal standing, by region
European Union
a legal, established cosmetic ingredient (topical), used in

a legal, established cosmetic ingredient (topical), used in finished skincare worldwide under standard cosmetic regulation. This is a cosmetic, not a medicine — no injection, no systemic use.

Evidence, by outcome

An honest grade per outcome — drawn from the evidence, not any catalogue. Hype and undemonstrated marketing claims grade low.

OutcomeEvidence base · effectGrade
Appearance of expression/dynamic wrinkles (the cosmetic use)
Solid cosmetic evidence for a topical; effect is mild and gradual, on the look of dynamic lines — not injection-strength
In-vitro: blocks muscle-cell contraction substantially; in-vivo cosmetic testing: visibly reduced wrinkle depth over ~28 days (36-subject studies)
B
Mechanism (mnAChR antagonism)
Mechanism is real and specific; topical delivery to muscle is the limiting factor for magnitude
Well-defined: reversible ε-subunit block, from Waglerin-1 pharmacology (McArdle 1999)
B
"Botox alternative" equivalence
Not equivalent to injected botulinum toxin; milder, temporary, surface-relaxing — honest framing needed
Marketing claim
D
Antioxidant (secondary claim)
Minor ancillary property; not the main reason to use it
Dose-dependent DPPH radical scavenging
C
Safety / tolerability (topical)
Good skin compatibility at cosmetic use levels; a topical peptide — not a systemic/injectable exposure
Widely used cosmetic ingredient; reversible action
A

Identity a synthetic cosmetic dipeptide engineered to mimic Waglerin-1, a neuromuscular-blocking toxin from snake venom — reframed as a needle-free, topical "Botox-like" wrinkle-relaxing active. It's a legitimate, widely-used cosmetic ingredient (not a drug, not an injectable), supplied by dsm-firmenich and formulated into serums/creams at low percentages. ## Mechanism (as proposed) at the neuromuscular junction, nerves release acetylcholine, which binds the muscle nicotinic acetylcholine receptor (mnAChR) to open channels, let Na⁺ in, depolarize the muscle, and trigger contraction. Syn-Ake's active dipeptide is a reversible antagonist of this receptor — modeled on Waglerin-1's selective block of the receptor's ε (epsilon) subunit — so it competes with acetylcholine, reduces Na⁺ influx and depolarization, and thereby dampens the micro-contractions of facial mimic muscles. Fewer repeated contractions → relaxed, smoothed expression lines. It's conceptually the same target logic as Botox (both quiet the nerve-to-muscle signal) but by a different, reversible, receptor-level mechanism, delivered topically rather than injected — which is why it's gentler and more gradual.

Sources — 4 cited
01McArdle JJ, Lentz TL, Witzemann V, et al. Waglerin-1 selectively blocks the epsilon form of the muscle nicotinic acetylcholine receptor. J Pharmacol Exp Ther. 1999 (the toxin pharmacology behind it).
02dsm-firmenich (Pentapharm) SYN-AKE® technical/cosmetic data — mnAChR antagonism; crow's-feet wrinkle-depth reduction over 28 days.
03Debono J, et al. Viper venom botox: the molecular origin and evolution of the waglerin peptides used in anti-wrinkle skin cream. J Mol Evol (biomimetic origin).
04Cosmetic clinical testing (36 subjects, 35–60 yr): reduced wrinkle depth/volume/number over 4 weeks; DPPH antioxidant activity. (Cosmetic ingredient; appearance claims, not medical.)
Review status
Not yet reviewed

A credentialed reviewer (PharmD / PhD / MD) will be named before this entry is finalised. Until then, treat it as a working draft. Last updated July 2026 (established cosmetic active; status stable).

Grades reflect the published evidence, not our interest. No dosing, reconstitution, or administration is published for research compounds — that restraint is deliberate.

Related compounds
Argireline (Acetyl Hexapeptide-8)C
Peptide
SNAP-8 (Acetyl Octapeptide-3)C
Peptide
Matrixyl (Palmitoyl Pentapeptide-4)B
Peptide
GHK-Cu (Copper Tripeptide-1)B
Peptide
AHK-Cu (Copper Tripeptide-3)C
Peptide
Explore by goal
Skin & aesthetic
Vallydia

A neutral reference and a lawful-lane shop. Registered in Spain. Information for those who seek it — never promotion.

Region — United States
ExploreRegisterCategoriesTrust & COA
ShopCosmetic peptidesJournal
TermsPrivacyCookiesReturnsShippingImprint

This site provides neutral scientific reference and sells only products lawful in your region. Nothing here is medical advice, a recommendation, or an offer to supply unapproved medicines. No dosing or administration is published for research compounds. Cosmetic peptides per Regulation (EC) 1223/2009. Unapproved injectable peptides are neither sold nor advertised in the EU (Directive 2001/83/EC, Title VIII). © 2026 Vallydia SL — Registered in Spain.

Syn-Ake — the snake-venom-inspired "needle-free Botox" peptide: the Temple Viper story and the evidence · Vallydia